Clear cell atypical fibroxanthoma: A clinicopathologic study

Journal of Cutaneous Pathology

Volumn 29, Issue 6, 2002, Pages 374-381

  Neil Crowson, A ^a,b   Carlson Sweet, Kim ^a   Macinnis, Colleen ^a   Taylor, James R ^b   Battaglia, Tammy ^b   LaMar, Walter L ^b   Minor, David ^a   Sutter, Steven ^a   Hill, Tamara ^c  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b ST JOHN MEDICAL CENTER   (United States)

^c Regional Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BLOOD CLOTTING FACTOR 13A; CARCINOEMBRYONIC ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD68 ANTIGEN; CYTOKERATIN; MELAN A; PROTEIN S 100; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; TUMOR MARKER;

AGED; AGING; ARTICLE; CASE REPORT; CELL PROLIFERATION; CELL STRUCTURE; CLEAR CELL CARCINOMA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FIBROXANTHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; PATHOLOGY; SPINDLE CELL CARCINOMA; SUN EXPOSURE; CARCINOMA; CHEMISTRY; DERMATOFIBROMA; MELANOMA; SKIN TUMOR; SUNLIGHT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; HISTIOCYTOMA, FIBROUS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; SKIN NEOPLASMS; SUNLIGHT; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS;

EID: 0035990410     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2002.290609.x     Document Type: Article

References (91)

1. Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases
2. Clear cell atypical fibroxanthoma
3. Clear-cell atypical fibroxanthoma: An uncommon histopathologic variant of atypical fibroxanthoma
4. Clear cell atypical fibroxanthoma
5. Spindle cell tumors of the skin of debatable origin. An immunocytochemical study
6. Atypical fibroxanthoma. A study of 14 cases emphasizing the presence of Langerhans histiocytes with implications for differential diagnosis by antibody panels
7. Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans
8. Atypical fibroxanthoma. Multiple immunohistologic profiles
9. Balloon cell melanoma
10. Sebaceous carcinoma of the vulva
11. S-100 protein distribution in liposarcoma: An immunoperoxidase study with special reference to the distinction of liposarcoma from myxoid malignant fibrous histiocytoma
12. Cutaneous metastasis of CNS chordoma
13. Chordoma cutis: A report of nineteen patients with cutaneous involvement of chordoma
14. Cutaneous parachordoma. A light microscopic and immunohistochemical report of two cases and review of the literature
15. Tricholemmal carcinoma. A study of seven cases
16. Signet-ring clear-cell basal cell carcinoma
17. Extramammary Paget's disease
18. Nodular hidradenoma and hidradenocarcinoma. A 10-year review
19. Clear cell dermatofibroma. Case report of an unusual fibrohistiocytic lesion
20. Dermatofibroma with monster cells
21. A retrospective analysis of immunohistochemical staining in identification of poorly differentiated round cell and spindle cell tumors - Results, reagents and costs
22. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: Comparison with four other melanoma markers
23. A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary, melanocytic nevi, and malignant melanomas
24. Cutaneous melanoma with myxoid features: Twelve cases with differential diagnosis
25. Histiocytic markers' in melanoma
26. KP1/CD68 expression in malignant neoplasms including lymphomas, sarcomas, and carcinomas
27. Use of monoclonal antibody 1H1, anticortactin, to distinguish normal and neoplastic smooth muscle cells: Comparison with anti-alpha-smooth muscle actin and antimuscle-specific actin
28. Anorectal malignant melanoma. A clinicopathologic study, including immunohistochemistry and DNA flow cytometry
29. Primary melanoma of the lung: A clinicopathologic and immunohistochemical study of eight cases
30. Ber-H2 (CD30) immunohistochemical staining in malignant melanoma
31. Primary melanocytic neoplasms of the central nervous systems
32. A histochemical and immunohistochemical study of extra-ocular sebaceous carcinoma
33. Immunohistochemical staining for androgen receptors: A sensitive marker of sebaceous differentiation
34. KP-1: Not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes
35. Epithelioid variant of pleomorphic liposarcoma: A study of 12 cases of a distinctive variant of high-grade liposarcoma
36. Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: Comparative evaluation with traditional diagnostic markers
37. Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections
38. Chordoma. Antibodies to epithelial membrane antigen and carcinoembryonic antigen in differential diagnosis
39. The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors
40. Expression of Ki-1 antigen (CD30) in mesenchymal tumors
41. Epithelial membrane antigen - A diagnostic discriminant in surgical pathology: Immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies
42. Parachordoma is immunohistochemically and cytogenetically distinct from axial chordoma and extraskeletal myxoid chondrosarcoma
43. Keratin subsets and monoclonal antibody HBME-1 in chordoma: Immunohistochemical differential diagnosis between tumors simulating chordoma
44. Chordomas of the mediastinum: Clinicopathologic, immunohistochemical, and ultrastructural study of six cases presenting as posterior mediastinal masses
45. Chondroid chordoma. A hyalinized chordoma without cartilaginous differentiation
46. Chordoma in childhood and adolescence. A clinicopathologic analysis of 12 cases
47. Cytokeratin subtyping in chordomas and the fetal notochord: An immunohistochemical analysis of aberrant expression
48. Leiomyosarcoma of the paratesticular region: A clinicopathologic study
49. Pleomorphic leiomyosarcoma: Clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma
50. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma
51. Leiomyosarcomas of the oral cavity: An unusual topographic subset easily mistaken for nonmesenchymal tumours
52. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas
53. Primary leiomyosarcoma of bone: A clinicopathologic, immunohistochemical, and ultrastructural study of 33 patients and a literature review
54. Cutaneous leiomyosarcoma
55. Epithelioid leiomyosarcoma of the skin and subcutaneous tissue. Clinicopathologic, immunohistochemical, and ultrastructural study of five cases
56. Neuroendocrine (Merkel cell) carcinoma with an intraepidermal component
57. Cutaneous neuroendocrine (Merkel cell) carcinoma: An immunophenotypic, clinicopathologic, and flow cytometric study
58. Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretoneurin in Merkel cell carcinoma of the skin. An immunohistochemical study on 18 cases suggesting two types of Merkel cell carcinoma
59. Differentiation between Merkel cell carcinoma and malignant melanoma: An immunohistochemical study
60. Merkel cell carcinoma. Histopathology, immunohistochemistry, and cytogenetic analysis
61. Immunohistochemical and immunoelectron microscopic demonstration of chromogranin A in formalin-fixed tissue of Merkel cell carcinoma
62. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites
63. Hodgkin's disease expressing follicular dendritic cell marker CD21 without any other B-cell marker: A clinicopathologic study of nine cases
64. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry
65. Epithelial markers and differentiation in adnexal neoplasms of the skin: An immunohistochemical study including individual cytokeratins
66. Desmoplastic trichilemmoma
67. Phenotypic heterogeneity of nodular hidradenoma
68. Clear cell eccrine carcinomas of the skin
69. Tricholemmal carcinoma: A study of seven cases
70. Clear cell carcinoma of the skin: A tricholemmal carcinoma?
71. Malignant hidroacanthoma simplex: A case report
72. Atypical fibroxanthoma. An unusual variant with osteoclast-like giant cells
73. Atypical fibroxanthoma with osteoclast-like multinucleated giant cells
74. Atypical fibroxanthoma with multinucleated giant cells
75. Pigmented atypical fibroxanthoma
76. Granular cell variant of atypical fibroxanthoma
77. Merkel cell carcinoma: Squamous and atypical fibroxanthoma-like differentiation in successive local tumor recurrences
78. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma
79. Atypical fibroxanthoma
80. Atypical fibroxanthoma of the skin with metastases
81. Metastasizing fibrous histiocytoma of the skin: A clinicopathologic and immunohistochemical analysis of three cases
82. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma
83. Factor XIIIa and the classic histiocytic markers in malignant fibrous histiocytoma: A comparative immunohistochemical study
84. Spindle-cell and pleomorphic neoplasms of the skin. A clinicopathological and immunohistochemical study of 30 cases, with emphasis on atypical fibroxanthomas
85. A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma: Use of monoclonal antibody KP-1 (CD68)
86. nm23 protein expression and p53 immunoreactivity in cutaneous fiberohistiocytic tumors
87. WAF1/CIP1 in aggressive- versus non-aggressive-growth basal cell carcinoma: A comparative study
88. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin
89. Two unusual tumors in a patient with xeroderma pigementosum: Atypical fibroxanthoma and basosquamous carcinoma
90. The biology of malignant melanoma